MPN Heroes Make a Difference in the Rare Blood Cancer Space

The FDA approved Ojjaara for intermediate or high-risk myelofibrosis, including primary myelofibrosis or secondary myelofibrosis (post-polycythaemia vera and post-essential thrombocythaemia), in adults with anemia.

Kathleen Watt, whose treatment for osteosarcoma involved a decade-long process of facial reconstruction, shares her story in the memoir “Rearranged.”

Nurse practitioner Charina Toste explains why it is important for patients to be empowered to have educated conversation with their care teams.

"I’m on a healthy footing, and that’s pretty miraculous," said singer-songwriter Andrew McMahon, an acute lymphoblastic leukemia survivor and founder of the Dear Jack Foundation.

We took a look back at the most noteworthy and compelling myeloprolifearative neoplasm stories from 2023.

Patients with MPNs can potentially experience long asymptomatic periods, and it’s up to patients and providers to remain vigilant as they monitor and manage symptoms.